Generation of HPV antigen-specific T cells from a naive T cell population

DE602016095221T2Active Publication Date: 2026-04-15CHILDRENS NAT MEDICAL CENT
View PDF 0 Cites -1 Cited by

Patent Information

Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
CHILDRENS NAT MEDICAL CENT
Filing Date
2016-10-31
Publication Date
2026-04-15

AI Technical Summary

Technical Problem

Current methods struggle to effectively expand HPV-specific T cells from naive donors due to the absence of memory T cells, posing challenges for treating HPV infections and associated malignancies, and existing approaches using viruses or virus-transformed cells are undesirable due to clinical risks and regulatory hurdles.

Method used

A method using overlapping peptide libraries pulsed onto antigen-presenting cells, combined with specific cytokines and selection methods, to generate HPV-specific T cells from naive T cells without live viruses, enabling robust expansion and storage for therapeutic use.

Benefits of technology

The method allows for the rapid and safe production of HPV-specific T cells with a mixed CD4+CD8+ phenotype, capable of recognizing multiple HPV antigens, which can be banked for off-the-shelf use in treating HPV infections and malignancies, and is applicable to other opportunistic viruses and malignancies.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.